You have 9 free searches left this month | for more free features.

Elbasvir-grazoprevir drug combination

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis c, Liver Transplant Infection, Kidney Transplant Infection Trial in Taichung (grazoprevir 100 mg/ elbasvir 50

Terminated
  • Chronic Hepatitis c
  • +2 more
  • grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®
  • Taichung, Taiwan
  • +1 more
Mar 14, 2021

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

Completed
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
  • (no location specified)
Jan 15, 2021

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
  • Riyadh, Saudi Arabia
    King Fahad Medical City
Nov 18, 2020

Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

Completed
  • Hepatitis C
  • (no location specified)
Jan 15, 2021

Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

Completed
  • Chronic HCV Infection
  • Elbasvir/Grazoprevir Fixed Dose Combination
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Sep 9, 2020

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

HCV Infection Trial in Worldwide (EBR/GZR FDC Tablet, Placebo, Grazoprevir Oral Granules)

Completed
  • HCV Infection
  • EBR/GZR FDC Tablet
  • +3 more
  • San Francisco, California
  • +14 more
Jun 8, 2021

Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Elbasvir / Grazoprevir Oral Tablet [Zepatier]
  • Cardiac MRI
  • Washington, District of Columbia
  • +1 more
Feb 1, 2023

Hepatitis C, Hemodialysis, Nosocomial Infection Trial in Philadelphia (Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier])

Completed
  • Hepatitis C
  • +2 more
  • Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier]
  • Philadelphia, Pennsylvania
    Penn Presbyterian Medical Center
Nov 17, 2021

Renal Failure Trial in Boston (elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination))

Completed
  • Renal Failure
  • elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination)
  • Boston, Massachusetts
    Massachusetts General Hospital
May 19, 2020

Hepatitis C Trial in Darlinghurst, Kingswood, Newcastle (Grazoprevir/elbasvir)

Terminated
  • Hepatitis C
  • Darlinghurst, New South Wales, Australia
  • +4 more
Feb 21, 2020

Hepatitis C, Renal Insufficiency, Chronic, Disorder of Transplanted Kidney Trial in Baltimore (Post-transplant Grazoprevir and

Active, not recruiting
  • Hepatitis C
  • +2 more
  • Post-transplant Grazoprevir and Elbasvir
  • Baltimore, Maryland
    University of Maryland Medical Center
Oct 5, 2021

Hepatitis C, Medication Adherence Trial in Bronx (AiCure, AiCure with gamification)

Completed
  • Hepatitis C
  • Medication Adherence
  • AiCure
  • AiCure with gamification
  • Bronx, New York
    Albert Einstein College of Medicine Division of Substance Abuse
Aug 19, 2021

Hepatitis C, Deglutition Disorders Trial in Nijmegen (Zepatier whole tablet, Zepatier crushed tablet)

Completed
  • Hepatitis C
  • Deglutition Disorders
  • Zepatier whole tablet
  • Zepatier crushed tablet
  • Nijmegen, Netherlands
    RTCCS Radboudumc
Oct 16, 2020

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg

Completed
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
  • Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
  • (no location specified)
Nov 11, 2019

Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)

Withdrawn
  • Hepatocellular Carcinoma
  • +3 more
  • Elbasvir / Grazoprevir Oral Tablet
  • (no location specified)
Sep 6, 2020

Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])

Withdrawn
  • Hepatitis C Virus Infection, Response to Therapy of
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Cairo, Almanial, Egypt
    Kasr Alainy Hospital
Apr 16, 2020

Hepatitis C, Substance Use Disorders, Substance Abuse, Intravenous Trial in Portland (elbasvir-grazoprevir (50 mg/100 mg))

Completed
  • Hepatitis C
  • +2 more
  • elbasvir-grazoprevir (50 mg/100 mg)
  • Portland, Oregon
  • +1 more
Oct 19, 2020

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

Completed
  • Hepatitis C
  • (no location specified)
Aug 5, 2019

Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

Completed
  • Chronic Hepatitis C
  • SOF/LDV (sofosbuvir/ledipasvir)
  • +3 more
  • Little Rock, Arkansas
  • +37 more
Dec 1, 2021

Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

Completed
  • Hepatitis C
  • (no location specified)
Jul 18, 2019